162 related articles for article (PubMed ID: 37174750)
1. New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation.
Ho CJ; Huang YH; Hsieh TY; Yang MH; Wang SC; Chen WJ; Sung WW; Chen SL
Healthcare (Basel); 2023 Apr; 11(9):. PubMed ID: 37174750
[TBL] [Abstract][Full Text] [Related]
2. Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients.
Ho CJ; Huang YH; Hsieh TY; Yang MH; Wang SC; Chen WJ; Lee TH; Sung WW; Chen SL
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640492
[TBL] [Abstract][Full Text] [Related]
3. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
[No Abstract] [Full Text] [Related]
5. The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database.
Lee HY; Tang JH; Chen YH; Wu WJ; Juan YS; Li WM; Chan TC
Int J Clin Oncol; 2021 Mar; 26(3):569-577. PubMed ID: 33231793
[TBL] [Abstract][Full Text] [Related]
6. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation.
Luo HL; Chiang PH; Cheng YT; Chen YT
Biomed Res Int; 2019; 2019():2979142. PubMed ID: 31058186
[TBL] [Abstract][Full Text] [Related]
8. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
[TBL] [Abstract][Full Text] [Related]
9. Using Hematuria as Detection of Post-kidney Transplantation Upper Urinary Tract Urothelial Carcinoma Is Associated With Delayed Diagnosis of Cancer Occurrence.
Lin SH; Luo HL; Chen YT; Cheng YT
Transplant Proc; 2017 Jun; 49(5):1061-1063. PubMed ID: 28583527
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.
Mir MA; Pandith AA; Mansoor S; Baba SM; Makhdoomi R; Ain QU; Anwar I; Para SA; Bhat AH; Koul AM; Manzoor U; Khan I; Beg A; Wani MS
Gene; 2023 Aug; 878():147583. PubMed ID: 37353040
[TBL] [Abstract][Full Text] [Related]
11. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma.
Kuo YH; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Lu JC; Li CF
Onco Targets Ther; 2022; 15():727-740. PubMed ID: 35795328
[TBL] [Abstract][Full Text] [Related]
13. CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.
Lee YY; Wu WJ; Huang CN; Li CC; Li WM; Yeh BW; Liang PI; Wu TF; Li CF
J Cancer; 2016; 7(6):711-21. PubMed ID: 27076853
[TBL] [Abstract][Full Text] [Related]
14. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center.
Du C; Zheng M; Wang Z; Zhang J; Lin J; Zhang L; Tian Y; Zhu Y
BMC Urol; 2023 Apr; 23(1):71. PubMed ID: 37118774
[TBL] [Abstract][Full Text] [Related]
16. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.
Chien CS; Luo HL; Ling CS; Chiang PH; Chen YT; Cheng YT
Int Urol Nephrol; 2016 Aug; 48(8):1261-1265. PubMed ID: 27193437
[TBL] [Abstract][Full Text] [Related]
17. Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients.
Yu J; Lee CU; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
Cancer Manag Res; 2019; 11():157-166. PubMed ID: 30636892
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Outcomes of Post-Kidney Transplantation Superficial Urothelial Carcinoma.
Huang GL; Luo HL; Chen YT; Cheng YT
Transplant Proc; 2018 May; 50(4):998-1000. PubMed ID: 29731099
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.
Kuo YH; Chan TC; Lai HY; Chen TJ; Wu LC; Hsing CH; Li CF
Front Oncol; 2021; 11():749142. PubMed ID: 34589439
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Chemotherapy in Patients with Locally Advanced Upper Tract Urothelial Carcinoma with or without Kidney Transplantation.
Chang NW; Huang YH; Sung WW; Chen SL
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
